This highlights the positive impact of awake brain mapping on the extent of resection of IDH-wildtype glioblastomas, which is already considered the gold standard for lower-grade and IDH-mutant diffuse gliomas [27]. This evidence concerns the gene IDH1 and glioblastoma.